These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone. Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221 [TBL] [Abstract][Full Text] [Related]
3. The changes of IGF binding proteins after rhGH administration to patients totally dependent on parenteral nutrition. Justová V; Lacinová Z; Melenovský V; Marek J; Holly JM; Hass T Growth Horm IGF Res; 2001 Dec; 11(6):407-15. PubMed ID: 11914029 [TBL] [Abstract][Full Text] [Related]
4. Systemic and splanchnic metabolic response to exogenous human growth hormone. Dahn MS; Lange MP Surgery; 1998 May; 123(5):528-38. PubMed ID: 9591005 [TBL] [Abstract][Full Text] [Related]
5. [Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis]. Liang LJ; Luo SM; Hu WJ Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(11):697-701. PubMed ID: 16008955 [TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human growth hormone on intestinal absorption and body composition in children with short bowel syndrome. Goulet O; Dabbas-Tyan M; Talbotec C; Kapel N; Rosilio M; Souberbielle JC; Corriol O; Ricour C; Colomb V JPEN J Parenter Enteral Nutr; 2010; 34(5):513-20. PubMed ID: 20852179 [TBL] [Abstract][Full Text] [Related]
7. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients? Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial]. Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure. Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964 [TBL] [Abstract][Full Text] [Related]
10. Integrated nutritional, hormonal, and metabolic effects of recombinant human growth hormone (rhGH) supplementation in trauma patients. Jeevanandam M; Holaday NJ; Petersen SR Nutrition; 1996; 12(11-12):777-87. PubMed ID: 8974104 [TBL] [Abstract][Full Text] [Related]
11. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. Khorram O; Laughlin GA; Yen SS J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536 [TBL] [Abstract][Full Text] [Related]
12. Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury. Klein GL; Wolf SE; Langman CB; Rosen CJ; Mohan S; Keenan BS; Matin S; Steffen C; Nicolai M; Sailer DE; Herndon DN J Clin Endocrinol Metab; 1998 Jan; 83(1):21-4. PubMed ID: 9435411 [TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. Garibotto G; Barreca A; Russo R; Sofia A; Araghi P; Cesarone A; Malaspina M; Fiorini F; Minuto F; Tizianello A J Clin Invest; 1997 Jan; 99(1):97-105. PubMed ID: 9011582 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats. Lo HC; Hinton PS; Yang H; Unterman TG; Ney DM JPEN J Parenter Enteral Nutr; 1996; 20(3):171-7. PubMed ID: 8776688 [TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. Holloway L; Butterfield G; Hintz RL; Gesundheit N; Marcus R J Clin Endocrinol Metab; 1994 Aug; 79(2):470-9. PubMed ID: 7519191 [TBL] [Abstract][Full Text] [Related]
17. Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia. Bourcigaux N; Arnault-Ouary G; Christol R; Périn L; Charbonnel B; Le Bouc Y Clin Ther; 2005 Feb; 27(2):246-51. PubMed ID: 15811488 [TBL] [Abstract][Full Text] [Related]
18. Effects of parenteral nutrition without and with growth hormone on growth hormone/insulin-like growth factor-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis. Cao J; Luo SM; Liang L; Lai J JPEN J Parenter Enteral Nutr; 2007; 31(6):496-501. PubMed ID: 17947606 [TBL] [Abstract][Full Text] [Related]
19. Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: a pilot open, randomized, and controlled clinical trial. Li N; Zhou L; Zhang B; Dong P; Lin W; Wang H; Xu R; Ding H Dig Liver Dis; 2008 Jul; 40(7):554-9. PubMed ID: 18164672 [TBL] [Abstract][Full Text] [Related]